发明名称 Novel IL-2 receptor-specific human immunoglobulins
摘要 <p>Compsn. comprises a pure human-like immunoglobulin (Ig) which (a) reacts specifically with p55 Tac protein and/or (b) inhibits binding of human interleukin-2 (IL-2) to its receptor. Also new are (1) human-like Ig having 2 pairs of light/heavy chains and able to react specifically with an epitope of a human IL-2 receptor with affinity at least 10 power 8 per mole, the chains including complementarily determg. regions (CDR's) and human-like framework regions (FR's), the CDR's being from different Ig molecules than FR's; (2) humanised Ig (hIg) which can bind to IL-2 receptors and contain at least one CDR from anti-Tac antibody in a human-like FR contg. at least one amino acid from the anti-Tac antibody; (3) nucleic acid encoding for human-like FR and at least one murine CDR, and (4) cells transfected with nucleic acid.</p>
申请公布号 SI8912489(B) 申请公布日期 2000.04.30
申请号 SI19890012489 申请日期 1989.12.28
申请人 PROTEIN DESIGN LABS, INC., (KORPORACIJA DRZAVE DELAWARE) 发明人 QUEEN CARY L.;SELICK HAROLD E.
分类号 C12N15/09;A61K;A61K38/00;A61K39/395;A61P3/10;A61P19/02;A61P21/04;A61P25/00;A61P29/00;A61P37/00;A61P37/06;C07K1/22;C07K14/435;C07K14/705;C07K14/715;C07K16/00;C07K16/08;C07K16/18;C07K16/24;C07K16/28;C07K16/46;C07K19/00;C12M;C12N1/15;C12N1/19;C12N1/21;C12N5/10;C12N5/28;C12N7/01;C12N15/00;C12N15/10;C12N15/13;C12P21/00;C12P21/08;C12R1/91;(IPC1-7):C12P21/08 主分类号 C12N15/09
代理机构 代理人
主权项
地址